Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

VNDA

VNDA News

Newswire

17:45

Vanda Pharmaceuticals Announces FDA Lifts Partial Hold on Tradipitant Motion-Sickness Study

17:23

FDA Clears Path for Vanda Pharmaceuticals' Motion Sickness Drug Trial

16:43

FDA Lifts Partial Clinical Hold on Tradipitant for Motion Sickness.

16:37

Vanda Pharmaceuticals shares surge 11.35% after-hours as FDA lifts partial clinical hold on Tradipitant motion sickness trials.

11:27

Vanda Pharmaceuticals' Tradipitant Under FDA Review Extension

View More

About VNDA

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More